Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dropless Postoperative Regimen After Cataract Surgery
NCT05157113Phase 4Recruiting
- Sponsor
- University of California, San Francisco
- Start
- May 2022
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone in cataract, sponsored by University of California, San Francisco. Started May 2022; status: recruiting.
02
Drugs
triamcinolone
03
Conditions
cataract
Beyond the preview
Go deeper on NCT05157113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05157113.